EAGLE PHARMACEUTICALS, INC. - Common stock, $0.001 par value per share (EGRX)

Historical Holders from Q1 2014 to Q3 2025

Type / Class
Equity / Common stock, $0.001 par value per share
Symbol
EGRX on OTC
Shares outstanding
12,986,368
Price per share
$2.70
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
12,350
Total reported value
$33,345
Share change
0
Number of holders
2
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of EAGLE PHARMACEUTICALS, INC. - Common stock, $0.001 par value per share (EGRX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Nantahala Capital Management, LLC 38% 0% $14,341,106 4,945,209 0% Nantahala Capital Management, LLC 30 Jun 2025
Union Square Park Capital Management, LLC 11% $2,807,930 1,485,677 Union Square Park Partners, LP 31 Dec 2024
Nantahala Capital Partners Limited Partnership 6.2% $1,532,091 810,630 NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP 16 Feb 2025
J. Goldman & Co LP 5.1% $1,934,613 667,108 J. Goldman & Co LP 30 Jun 2025
As of 30 Sep 2025, EAGLE PHARMACEUTICALS, INC. - Common stock, $0.001 par value per share (EGRX) has 2 institutional shareholders filing 13F forms. They hold 12,350 shares. of 12,986,368 outstanding shares (0.1%) .

Institutional Holders of EAGLE PHARMACEUTICALS, INC. - Common stock, $0.001 par value per share (EGRX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q3 12,350 $33,345 270% 2
2025 Q2 12,350 $35,815 290% 2
2025 Q1 12,350 $12,103 -$32,538 98% 2
2024 Q4 79,081 $39,105 -$31,377,467 50% 10
2024 Q3 8,556,159 $31,916,789 -$6,511,959 373% 64
2024 Q2 9,907,037 $55,472,117 -$2,734,414 560% 74
2024 Q1 10,455,755 $54,789,570 +$2,029,783 524% 91
2023 Q4 38,900 $203,447 +$128,658 523% 1
2023 Q3 10,331,989 $162,859,531 -$8,096,141 1,577% 105
2023 Q2 10,755,896 $209,028,340 -$25,867,239 1,944% 120
2023 Q1 11,782,213 $334,227,635 +$6,361,041 2,837% 152
2022 Q4 11,555,279 $337,769,826 +$2,942,831 2,923% 151
2022 Q3 9,348,577 $247,032,716 -$9,389,427 2,642.02% 137
2022 Q2 11,351,704 $499,549,572 +$17,096,092 4,443.06% 154
2022 Q1 10,931,539 $540,884,605 +$1,105,104 4,949.1% 151
2021 Q4 10,882,827 $553,882,097 -$54,723,034 5,092% 154
2021 Q3 11,809,331 $658,523,787 -$12,772,283 5,578% 147
2021 Q2 11,866,689 $508,136,498 -$4,781,129 4,279.98% 137
2021 Q1 12,101,980 $504,803,422 -$2,417,194 4,173.94% 149
2020 Q4 12,233,120 $569,684,683 -$4,948,139 4,656.98% 156
2020 Q3 12,275,304 $521,435,860 -$21,049,340 4,247.98% 160
2020 Q2 12,906,558 $619,270,103 -$12,622,967 4,798% 158
2020 Q1 13,192,063 $607,216,914 -$10,222,198 4,600% 163
2019 Q4 13,115,027 $787,812,171 +$6,081,771 6,007.88% 173
2019 Q3 13,164,739 $744,772,612 -$18,885,925 5,656.93% 180
2019 Q2 13,499,888 $751,542,030 +$26,520,976 5,567.73% 176
2019 Q1 13,163,199 $664,577,802 -$20,168,103 5,049% 172
2018 Q4 13,903,688 $560,009,838 -$99,034,028 4,028.73% 174
2018 Q3 15,140,728 $1,049,504,294 +$1,474,989 6,932.98% 183
2018 Q2 15,281,921 $1,156,290,505 -$22,925,000 7,565.97% 177
2018 Q1 15,664,607 $825,376,321 -$8,756,620 5,268.99% 168
2017 Q4 15,834,365 $845,965,384 +$1,802,323 5,341.93% 163
2017 Q3 15,744,499 $938,864,969 -$209,659,966 5,963.97% 162
2017 Q2 15,326,048 $1,209,015,513 +$310,411,394 7,888.9% 167
2017 Q1 16,442,698 $1,363,355,862 +$101,167,126 8,293.98% 144
2016 Q4 16,455,919 $1,305,495,671 -$58,113,909 7,933.98% 146
2016 Q3 16,738,705 $1,171,435,380 +$53,742,069 7,000% 134
2016 Q2 17,147,075 $665,218,561 +$58,005,783 3,878.99% 112
2016 Q1 15,657,744 $633,882,000 -$1,095,912 4,049.92% 115
2015 Q4 14,904,350 $1,321,835,128 +$76,412,905 8,866.98% 130
2015 Q3 14,018,559 $1,037,787,999 +$40,405,376 7,403% 116
2015 Q2 13,363,575 $1,079,928,217 +$142,954,786 8,085.99% 118
2015 Q1 11,689,865 $489,456,000 +$142,381,244 4,188.94% 68
2014 Q4 9,203,739 $142,654,000 +$21,828,041 1,549.86% 28
2014 Q3 2,974,685 $37,573,341 +$13,805,064 1,265.01% 24
2014 Q2 1,739,800 $24,925,337 -$1,566,709 1,432.86% 27
2014 Q1 1,913,224 $24,390,000 +$24,377,028 1,274.88% 28